Urge Congress to Increase Funding for Ovarian Cancer Research and Pass the FY 2022 Spending Bills

Congress adjourned last year without completing work on the Fiscal Year (FY) 2022 spending bills. Consequently, FY 2022 funding for the Department of Defense (DoD) Ovarian Cancer Research Program (OCRP) remains in limbo. Not only must Congress take action to complete FY 2022 spending bills, but we must also convince Senators that the House-recommended $45 million appropriation for the DoD OCRP is necessary to preserve current investments in ovarian cancer research and ensure that discoveries in the field continue. Please visit the SGO website to send a prewritten email message to your U.S. Representative and two U.S. Senators requesting their support.

Take Action